title: Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.
abstract: Cancer metastasis, the process of cancer cell migration from a primary to distal location, typically leads to a poor patient prognosis. Hematogenous metastasis is initiated by intravasation of circulating tumor cells (CTCs) into the bloodstream, which are then believed to adhere to the luminal surface of the endothelium and extravasate into distal locations. Apoptotic agents such as tumor necrosis factor (TNF) apoptosis-inducing ligand (TRAIL), whether in soluble ligand form or expressed on the surface of natural killer (NK) cells, have shown promise in treating CTCs to reduce the probability of metastasis. The role of hemodynamic shear forces in altering the cancer cell response to receptor-mediated apoptosis has not been previously investigated. Here, we report that human colon cancer COLO 205 and prostate cancer PC-3 cells exposed to a uniform fluid shear stress in a cone-and-plate viscometer become sensitized to TRAIL-induced apoptosis. Shear-induced sensitization directly correlated with the application of fluid shear stress, and TRAIL-induced apoptosis increased in a fluid shear stress force- and time-dependent manner. In contrast, TRAIL-induced necrosis was not affected by the application fluid shear stress. Interestingly, fluid shear stress did not sensitize cancer cells to apoptosis when treated with doxorubicin, which also induces apoptosis in cancer cells. Caspase inhibition experiments revealed that shear stress-induced sensitization to TRAIL occurs via caspase-dependent apoptosis. These results suggest that physiological fluid shear force can modulate receptor-mediated apoptosis of cancer cells in the presence of apoptotic agents.
authors.affiliation: Department of Biomedical Engineering, Cornell University, Ithaca, New York.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mitchell
authors.affiliation: Department of Biomedical Engineering, Cornell University, Ithaca, New York.
authors.forename: Michael R
authors.initials: MR
authors.lastname: King
keywords: TRAIL; cancer; caspase; death receptors; mechanotransduction; shear stress
references.citation: Mol Cancer Ther. 2007 Mar;6(3):1031-8
references.pmid: 17339365
references.citation: Adv Pharmacol. 1994;29B:105-26
references.pmid: 8996604
references.citation: Lancet Oncol. 2002 Jan;3(1):53-7
references.pmid: 11905606
references.citation: PLoS One. 2011;6(5):e20348
references.pmid: 21637818
references.citation: Oncogene. 2001 Apr 19;20(17):2122-33
references.pmid: 11360196
references.citation: Front Oncol. 2012 Jul 24;2:79
references.pmid: 22837985
references.citation: Biophys J. 2012 Apr 18;102(8):1804-14
references.pmid: 22768936
references.citation: Bioessays. 2002 Oct;24(10):885-93
references.pmid: 12325121
references.citation: PLoS One. 2012;7(6):e39290
references.pmid: 22723988
references.citation: Am J Physiol Cell Physiol. 2003 Apr;284(4):C977-87
references.pmid: 12477667
references.citation: Nat Rev Cancer. 2002 Nov;2(11):850-61
references.pmid: 12415255
references.citation: J Control Release. 2012 Jun 28;160(3):609-17
references.pmid: 22421423
references.citation: Nat Rev Cancer. 2011 Jun 24;11(7):512-22
references.pmid: 21701513
references.citation: Prog Hemost Thromb. 1982;6:139-77
references.pmid: 6762611
references.citation: Blood. 2008 Nov 1;112(9):3650-60
references.pmid: 18544680
references.citation: Microcirculation. 2003 Apr;10(2):167-78
references.pmid: 12700585
references.citation: Mol Cancer Res. 2012 Jan;10(1):75-85
references.pmid: 22112940
references.citation: Leukemia. 2002 Jan;16(1):67-73
references.pmid: 11840265
references.citation: Nat Rev Cancer. 2002 Jun;2(6):420-30
references.pmid: 12189384
references.citation: Front Oncol. 2012 Jul 02;2:69
references.pmid: 22783545
references.citation: Cancer Metastasis Rev. 1995 Dec;14(4):279-301
references.pmid: 8821091
references.citation: Trends Cell Biol. 2007 Jan;17(1):44-50
references.pmid: 17141502
references.citation: Clin Chem. 2012 May;58(5):846-53
references.pmid: 22344286
references.citation: J Biol Chem. 2005 Dec 9;280(49):41047-56
references.pmid: 16199534
references.citation: Nat Rev Cancer. 2006 Jun;6(6):449-58
references.pmid: 16723991
references.citation: Cancer Res. 2002 Nov 15;62(22):6731-9
references.pmid: 12438274
references.citation: J Biol Chem. 1996 May 31;271(22):12687-90
references.pmid: 8663110
references.citation: J Clin Invest. 1999 Jul;104(2):155-62
references.pmid: 10411544
references.citation: Biochem Biophys Res Commun. 2010 May 21;396(1):95-100
references.pmid: 20494118
references.citation: Nat Med. 2002 Aug;8(8):808-15
references.pmid: 12118245
references.citation: Biotechnol Bioeng. 2009 Apr 15;102(6):1692-702
references.pmid: 19073014
references.citation: Nat Immunol. 2000 Dec;1(6):489-95
references.pmid: 11101870
references.citation: J Immunol. 2002 Feb 1;168(3):1356-61
references.pmid: 11801676
references.citation: Cell. 1994 Jan 28;76(2):301-14
references.pmid: 7507411
references.citation: Mol Cancer Ther. 2006 Jan;5(1):160-9
references.pmid: 16432175
references.citation: Nat Rev Cancer. 2012 Feb 24;12(3):210-9
references.pmid: 22362216
references.citation: Apoptosis. 2003 Dec;8(6):587-99
references.pmid: 14739604
references.citation: Oncogene. 2006 Aug 24;25(37):5125-33
references.pmid: 16607283
references.citation: Carcinogenesis. 2010 Nov;31(11):1956-63
references.pmid: 20876284
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Cancer Res. 2007 Jan 1;67(1):218-26
references.pmid: 17210702
references.citation: Science. 1998 Aug 28;281(5381):1312-6
references.pmid: 9721091
references.citation: J Biomech. 2007;40(7):1484-92
references.pmid: 16987520
references.citation: Ann N Y Acad Sci. 2005 Nov;1056:379-87
references.pmid: 16387703
references.citation: Science. 2011 Mar 25;331(6024):1559-64
references.pmid: 21436443
references.citation: Oncogene. 2001 Feb 15;20(7):859-68
references.pmid: 11314019
references.citation: J Natl Cancer Inst. 2003 Apr 16;95(8):611-21
references.pmid: 12697854
references.citation: N Engl J Med. 1981 Jul 16;305(3):139-53
references.pmid: 7017406
references.citation: Nat Med. 2001 Jan;7(1):94-100
references.pmid: 11135622
references.citation: Mol Pharm. 2012 Aug 6;9(8):2219-27
references.pmid: 22724630
references.citation: J Exp Med. 2001 Mar 19;193(6):661-70
references.pmid: 11257133